213.34 USD
↗ 9.27 (4.54%)LIVE (AS OF 12:07 PM EDT)
Axsome Therapeutics, Inc
AXSMNASDAQ • USD
Market: OPEN
Shares of Axsome Therapeutics, Inc (AXSM) are trading at $213.34. Technicals currently rate "Neutral" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, AXSM trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Sep 15, 2026.
Open?$202.95
High?$214.45
Low?$200.71
Prev. Close?$204.07
Volume?322.0K
Avg. Volume?641.3K
VWAP?$210.97
Rel. Volume?0.50x
Bid / Ask
Bid?$211.97 × 100
Ask?$225.66 × 100
Spread?$13.69
Midpoint?$218.82
Valuation & Ratios
Market Cap?10.7B
Shares Out?52.4M
Float?40.2M
Float %?78.1%
P/E Ratio?N/A
P/B Ratio?128.32
EPS?-$3.66
Dividend?0.00%
Ex-Dividend?N/A
RelatedJAZZ
News
Profile
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Address
ONE WORLD TRADE CENTER, 29TH FLOOR
NEW YORK, NY 10007
Phone: (212) 332-3241
NEW YORK, NY 10007
Phone: (212) 332-3241
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?85
Short Sent.?40
Piotroski F-Score?4/9Mixed
Altman Z-Score?7.37Safe
Confidence?66%Moderate
Short InterestHigh
Short % of Float?7.66%Elevated
Short Interest?3.1M
Days to Cover?5.8
Free Float40.2M
Avg Daily Volume528.0K
Settlement Date2026-08-31
Financial Health
Current Ratio?1.43Adequate
Quick Ratio?1.34Adequate
Cash Ratio?0.69Adequate
Debt/Equity?2.36High
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?128.32HIGH▾
Peers50
S&P3
P/S?13.76HIGH▾
Peers50
S&P3
P/FCF?N/A▾
EV/EBITDA?-59.0CHEAP▾
Peers100
S&P97
EV/Sales?13.61HIGH▾
Peers50
S&P5
Returns & Efficiency
ROE?-230.1%WEAK▾
Peers50
S&P3
ROA?-25.2%WEAK▾
Peers50
S&P3
Cash Flow & Enterprise
FCF?$-71959000
Enterprise Value?$10.6B
Fundamentals ratios updated end of day